The result of our study was consistent with the previous finding that Gent treatment was able to significantly reduce IL-6 and IL-1β secretion by TNF-α-stimulated RA-FLS (Zhang et al., 2019). This evidence concerns the gene IL1B and rheumatoid arthritis.